TITLE

SEQUELAE OF VENOUS THROMBOSIS OF THE LOWER LIMBS FOLLOWING VARIOUS METHODS OF TREATMENT

AUTHOR(S)
Höjensgård, I. C.
PUB. DATE
December 1956
SOURCE
Angiology;Dec1956, Vol. 7 Issue 6, p517
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
On the basis of reported follow-up studies on the value of various methods of treatment, the degrees of severity of sequelae of thrombosis of the lower limb are compared. Active movements and ambulation seem to followed by sequelae of the same degree of severity as those resulting from treatment with anticoagulants and active movement. The history of active-movement therapy is briefly reviewed.
ACCESSION #
16357996

 

Related Articles

  • Management of Thrombotic and Cardiovascular Disorders in the New Millenium. Fareed, Jawed; Hoppensteadt, Debra A.; Bick, Rodger L. // Clinical & Applied Thrombosis/Hemostasis;Apr2003, Vol. 9 Issue 2, p101 

    Anticoagulants and antithrombotic drugs have played a key role in the prophylaxis, treatment and surgical/interventional management of thrombotic and cardiovascular disorders. There are several newer drugs which are currently developed for the anticoagulant management of cardiovascular diseases...

  • Antiplatelet Agents and Thrombin Inhibitors: Combined Modality Therapy. Gensini, Gian Franco; Colella, Andrea; Comeglio, Marco // Clinical & Applied Thrombosis/Hemostasis;Apr1997, Vol. 3 Issue 2, p82 

    Presents a study which evaluated the combined use of antiplatelet agents and thrombin inhibitors in the treatment of antithrombotic prophylaxis in patients with prosthetic valves or unstable angina. Rationale for the combined use of the drugs; Limitations of antiplatelet agents and oral...

  • INRs and point of care testing. Murray, E. T.; Greaves, M. // BMJ: British Medical Journal (International Edition);7/5/2003, Vol. 327 Issue 7405, p5 

    Reports on the development and adoption of instruments for determining the international normalised ratio (INR) at the point of care for monitoring treatment with coumarin anticoagulants. Use of coumarin anticoagulants in the treatment of thrombosis; How a difference exists between the...

  • Lupus Anticoagulant Assays: Questions Answered and to Be Answered. Teruya, Jun; West, Aaron G.; Suell, Mary Nell // Archives of Pathology & Laboratory Medicine;Jun2007, Vol. 131 Issue 6, p885 

    Context.—Lupus anticoagulants are antibodies with heterogenous specificities to phospholipids. They have been associated with clinical syndromes consisting of thrombosis and recurrent fetal loss. Objective.—To address questions about the laboratory assay aspects of lupus...

  • PERIPHERAL ARTERIAL EMBOLISM. Haimovici, Henry // Angiology;Feb1950, Vol. 1 Issue 1, p20 

    The article cites several studies related to peripheral arterial embolism. Ever since 1911, when the first successful embolectomy was performed, there has been a steadily growing literature on peripheral arterial embolism. From then until 1934, embolectomy was considered the only weapon against...

  • clopidogrel.  // Royal Society of Medicine: Medicines;2002, p161 

    The article presents information on clopidogrel, an antiplatelet antithrombotic drug which is used to prevent thrombosis, but does not have an anticoagulant action. It works by stopping platelets sticking to one another or to the walls of blood vessels. It is used to reduce complications in...

  • Orgaran.  // Royal Society of Medicine: Medicines;2002, p413 

    The article presents information on Orgaran which is a proprietary, prescription-only preparation of the heparinoid, danaparoid sodium. It can be used as an anticoagulant for the prevention of deep vein thrombosis, and is available in a form for injection.

  • Mechanical Prosthetic Heart Valve Thrombosis Despite Optimal Anticoagulation in a Patient with Congenital Thrombophilia (Factor V Leiden). Pegoraro, Cinizia; Biasiolo, Alessandra; Iliceto, Sabino; Pengo, Vittorio // Clinical & Applied Thrombosis/Hemostasis;Jan2003, Vol. 9 Issue 1, p89 

    Failure of anticoagulant therapy in a patient with a St. Jude heart valve in the mitral position is reported. After 8 years of optimal anticoagulation at an International Normalized Ratio between 2.5 and 3.5, a floating thrombus was discovered by chance during transthoracic echocardiography and...

  • Corrigendum to The role of novel anticoagulants in the management of venous thromboembolism.  // Vascular Medicine;Aug2014, Vol. 19 Issue 4, p337 

    The authors (Nedaa Skeik, Caleb J Murphy and Brandon R Porten) would like to highlight the following corrections to Table 2 in their review article, DOI: 10.1177/1358863X14534309. The review was printed in Vascular Medicine 2014; 19: 205–214. The authors would like to apologize for any...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics